Ademi LLP is investigating Accelerant (NYSE: ARX) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Thoma Bravo.
Accelerant shareholders may elect to receive $20.25 per share in cash in an all-cash transaction with an enterprise value of more than $4 billion.
Accelerant insiders will receive substantial benefits as part of change of control arrangements.
The transaction agreement unreasonably limits competing transactions for Accelerant by imposing a significant penalty if Accelerant accepts a competing bid. We are investigating the conduct of the Accelerant board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.
Join this Action